Role of Pharmacists in Drug Regulatory Affairs

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Biopharmaceutical Quality
BACKGROUND: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh,
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
Batch Reworking and Reprocessing
Introduction to Regulation
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
Regulatory Body MODIFIED Day 8 – Lecture 3.
Regulatory Issues US and Abroad BIT 230 Chapters 9-11 Huxsoll.
Your global support in Europe Over 20 years of experience ELM Pharmaceutica.
“WHO TRS Requirements on Pharmaceuticals Moving in International Commerce” Dr. A. Ramkishan Deputy Drugs Controller (India)-(Incharge) Office of Deputy.
The “ Operon Strategist” is working towards the catalyzing and ensuring the strategic development of the clients in the areas of Regulatory approvals,
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Personnel Basic Principles of GMP Workshop on
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Why Pharmacy? “Indian pharmaceutical Industry is one of the world’s largest and most developed”
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Regulatory Overview.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
ASEAN GMP TRAINING MODULE PERSONNEL
Introduce on Imported Foods System in Korea - Under The Food Sanitation Act - Korea Food and Drug Administration.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
The South African perspective
Pharmacovigilance Programme of India
INTRODUCTION TO RA.
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
PRODUCT TRANSFER.
REPORT ON THE MINISTERIAL TASK TEAM REVIEW OF MEDICINES CONTROL COUNCIL AND RECOMMENDATIONS ON THE NEW REGULATORY AUTHORITY PRESENTATION TO HEALTH PORTFOLIO.
Regulatory Big Brother of Biotechnology. Role of FDA FDA was designed to promote and protect the public’s health Food and Drug Cosmetic Act first passed.
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
Important informations
ACCESS TO MEDICINES - POLICY AND ISSUES
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Module 1 Biotechnology Basics Copyright © Texas Education Agency All rights reserved.
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Link between legal framework of VMP regulation and VICH GLs in Japan Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan.
The Regulation on Cell Therapy Products in Japan
PHARMA HELPLINE SOCIETY we care,we assist, we help Announces on line courses for the overall development of pharmacy professionals and students. These.
INTRODUCTION TO DRUG REGULATORY AFFAIRS. Regulatory Affairs ???  Regulatory Affairs is a comparatively new profession which has developed from the desire.
Good Manufacturing Practices
RAC Regulatory Affairs Certification
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Recent Evolution of New Drug Review and Approval System in Korea
נמטוציטים משושנת ים Eli. S Lec. No.2.
Biotechnology R&D.
Pharmaceutical Quality Control & current Good Manufacturing Practice
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Careers in Biomanufacturing
Quality Assurance and Quality Control in Generics
Industrial Pharmacy.
American Society for Quality Region 5 Quality Conference
Good Manufacturing Practices GMP ممارسات التصنيع الجيد
Beyond Academia.
Good Laboratory Practices
GMP Inspection Process
Dr Manisha Shridhar Regional Advisor WHO-SEARO
EU Food Safety Requirements: - Hygiene of Foodstuffs -
SID & GP MINPROMTORG OF RUSSIA Corporate Communication Center
Storage and distribution
Interconnection of good practices: from development to distribution
Presentation transcript:

Role of Pharmacists in Drug Regulatory Affairs Dr Dehghan M H M.Pharm. PhD. Y.B Chavan College of Pharmacy, Aurangabad, M.S

Drug Regulatory Affairs For any activity with Drugs; no (=does not belong to drug regulatory affairs) Prior authorisation needed? yes By whom? (the authority) Based on which (objective and subjective) criteria? Subject to regular control (quality, inspection)? By whom? (the authority)

Some drug related activities : Research (Chemical, Biological) Clinical Trials on Human Beings Manufacture Import Registration Evaluation Authorisation (Wholesale) Distribution continued

Some drug related activities (cont’d)… (Retail) Distribution Pricing Prescribing Reimbursement/Subsidy Advertising (if any) Special Control (eg. Narcotic Drugs) Post-marketing Surveillance Central Drug Control Lab Pharmacovigilance (Adverse Effect Reporting System)

Organization and Regulations related to Health in India Based on the federal nature of constitution, areas of operation have been divided into Central Government and State Government 7th schedule of constitution describes 3 items namely: Union List, State List and Concurrent list. Some items like Public health, Hospitals, Sanitization etc fall in the State list. The items having wider ramification at the national level like Family Welfare, Population Control, Medical Education, Prevention of Food Adulteration, Quality Control in manufacturing of drugs etc have been included in the Concurrent list.

Drug Regulatory System in India Drug is in concurrent list of Indian Constitution. It is governed by both Centre and State Governments under the Drugs & Cosmetics Act, 1940 and Rules 1945 thereunder. The principle on which the Drugs & Cosmetics Act function is by a system of licensing under which all the activities involved in manufacture, sale and distribution of Drugs & Cosmetics are controlled.

Indian Drug Regulatory System: Government of India Ministry of Health & Family Welfare DGHS Central Drugs Standard Control Organization (CDSCO) Ministry of Science & Technology Indian Council of Medical Research (ICMR) Council of Scientific & Industrial Research (CSIR) BARC (Radioactive) Ministry of Chemicals & Petrochemicals National Pharmaceutical Pricing Authority (NPPA) Department of Chemical & Petrochemicals (DCP) Department of Pharmaceuticals Ministry of Commerce & Industry Patent Office Dept. of Commerce & Pharmexil Controller General of Patent DGFT Ministry of Environment & Forest GEAC-[Genetic Engineering Approval Committee] Department of Biotechnology r-DNA Advisory Committee Review Committee Genetic Manipulation

Regulatory/Apex/Committee Functions CDSCO Central Drugs Standard Control Organization (1948) Laying down standards, Clearance of new drugs, Banning Drugs, Clinical Trails etc. ICMR Indian Council of Medical Research (1911) Formulates, Coordinates and Promotes biomedical research & Ethical Principles GEAC Genetic Engineering Approval Committee (1989) Manufacture, Use, Import of Hazards Microorganisms/Genetically Engineered Organisms or Cells  DBT Department of Biotechnology (1986) It promote transgenic research, molecular biology of human genetic disorders, brain research, and commercialization of diagnostic kits and vaccines for communicable diseases AERB Atomic Energy Review Board (1983) Promotes Radio therapy & Research, Safety review for Gamma Irradiators (Devices) BARC Bhabha Atomic Research Centre (1967) Promotes Isotopes application in Medicine & also monitoring usage of radioactive materials DTAB Drug Technical Advisory Board (1950) To advise Central & State Govt. on Technical Matters arising out of the Drugs & Cosmetics RCGM Review Committee on Genetic Manipulation (1989) No Objection Certificate for Clinical Trial & also r-DNA strains, DCC Drug Consultative Committee (since 1951) Advisory Committee to DTAB and Central & State Govt. for uniform implementation of Various provisions of the Act

Central Drugs Standard Control Organization CDSCO is a separate division comes under DGHS, headed by DCG(I) Public health is one of the major objectives of Govt. of India and to achieve this it is important that drugs/vaccines are available to the public are of Quality, Safety, Purity and Efficacious. CDSCO zonal (N,S,E,W)& sub zonal (Andhra, Gujarat) offices

State Drug Control Authority Responsible for the testing, manufacturing, sale and distribution of drug: Licensing , approval of drug formulations manufacturing, monitoring quality of manufactured and marketed drug & cosmetics, inspection, investigation & prosecution, recall of substandard drugs

Some Regulatory Authorities and Agencies Worldwide USFDA (United States Food and Drug Administration) CFR (Code Of Federal Regulations) Centre for Biologics Evaluation and Research (CBER) Center for Drug Evaluation and Research (CDER) Centre for Drug Devices and Radiological Health (CDRH) Centre for Food safety and Applied Nutrition (CFSAN) Centre for Veterinary Medicine (CVM) -------------------------------------------------------------------------------------------------------------------------------------- TGA (Therapeutic Goods Administration) MHRA (Medicines & Healthcare Regulatory Agency) MCC (Medicine Control Council) ICH guidelines (International Conference on Harmonization) WHO (World Health Organization )

Indian Pharmaceutical Industry Industry size : 25.8 Bn USD Exports : 13.2 Bn USD Imports: 3.52 Billion USD Industry is growing @ 20% p.a Domestic Market 2011-2012: 12.6 Bn USD 4th Largest in world in terms of Volume & ranks 13th in terms of Value Export of Biotech products & Biopharmaceuticals ~US $1.36 Bn Export of Vaccines- US $507.9 million (US $ 42 Bn by year 2015) Manufacturing Facilities 172 US FDA Approved India Stood First Globally with 2759 DMF filling Out of 7886 DMFs US Pharmacopoeia has office in Hyderabad, India USFDA has country office in Delhi, Mumbai 9,000 manufacturing units in the country 600,000 Retail & Wholesale Shops in India 6th largest supplier of HIV drugs after Germany Drugs from India are exported to more than 200 countries Vaccines from India are exported to more than 151 countries

Pharmacists in the Pharmaceutical Industry AREA OF PHARMA INDUSTRY HANDS ON/SUPERVIOSORY ROLE RESEARCH & DEVELOPMENT Drug discover, reserve engineering, formulation and process development, up scaling from pilot to manufacturing, trouble shooting, stability, packaging development PRODUCTION/MANUFACTURING Production/manufacturing of bulk drugs & intermediate finished medicines, vaccines & other biological products, veterinary medicines, ayurvedic medicines, diagnostic products & medical devices. PACKAGING Various stages of packaging of pharmaceuticals QUALITY CONTROL Testing throughout the life cycle of the drug and finished product. QUALITY ASSURANCE Preparing, reviewing & submitting documents, conducting trainings, internal audits, assuring total quality management. SALES & MARKETING Strategic planning, team management and marketing of pharmaceuticals. Working as medical representative. REGULATORY AFFAIRS Preparing, reviewing, communicating, submitting registration documents on pharmaceuticals to regulatory agencies to get R&D testing, production & marketing approvals, issues related to patents

Importance of Regulatory Affairs Authorization for Journey of Product from the Laboratory to Pharmacy Shop (Discovery to Market) Huge investments and high stake in commercialization of new pharmaceutical product. “Right First Time” approach is necessary as time taken for the product to reach market is critical for success Foremost point of contact between the company and regulatory authorities. Coordination of scientific endeavors with regulatory demands throughout life of the product. Helps company meet all regulations and guidelines thus maximizes profits.

Pharmacists As Drug Regulatory Affairs Professionals Drug Regulatory Affairs Department Industry Regulatory Authority Government Teaching & Training Academia

Regulatory Affairs Department Drug regulatory affairs starts right from drug discovery and product development, its manufacture up to the marketing for end use. Keeps track on the legislation of countries where company wishes to market their products. Analysis of legal as well as scientific requirements for marketing authorization. Prepares submissions for regulatory review and ensures all regulatory compliance.

Regulatory Authorities Assessment of all submissions and technical reports. Generation of assessment report after critical review of scientific evidences submitted by the DRA department to establish quality, safety, efficacy within acceptable limits. Final Decision/Authorization.

Regulatory Process Pharmaceutical product Judgment taken Submitted to regulatory authority Verification Repetition of experiment or Reconstruction of all activities activities (Direct confirmation) (Indirect confirmation) Judgment taken Accept / Reject

DRUG DISCOVERY & DEVELOPMENT: REGULATORY REQUIRMENTS

GMP :REGULATORY ASSESMENT OF FACILITIES Buildings and Facilities Warehouse Facilities Sampling & Dispensing Manufacturing Areas IPQC areas Records and Reports Process Controls Cleaning Process Validation SOPs Reworks Ingredients controls Training Investigations Lab Controls Utilities Stability Programs

GLP : Concerns as Per Schedule L1 (Rule 74, 78 & 150E), Drugs & Cosmetics Act 1940 Storage and Archival General Requirements Premises Raw Data Personal Protocols and Specifications Archive Equipments Chemicals and Reagents Standard Operating Procedures GLP Good House Keeping and Safety Management Review Maintenance, Calibration, and Validation of Equipments Internal Quality System Audits Reference Materials Quality System Microbiological Cultures 21

Requirements of an Ideal Regulatory Affairs Professional Considerable Knowledge and understanding of legal and scientific matters. Communicative Competencies both Written and Oral. Analytical skills. Presentation skills Diligent, Sensitive and Sincerity in executing the strategies and tactics needed to obtain approvals/permissions /licenses.

THANK YOU